End-of-day quote
Shanghai S.E.
06:00:00 2024-06-02 pm EDT
|
5-day change
|
1st Jan Change
|
13.71
CNY
|
-1.58%
|
|
-4.46%
|
-19.45%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
23,252
|
22,302
|
23,778
|
15,988
|
25,427
|
20,482
|
-
|
-
|
Enterprise Value (EV)
1 |
29,451
|
23,121
|
23,086
|
14,968
|
23,635
|
17,776
|
16,961
|
16,053
|
P/E ratio
|
23.4
x
|
19.7
x
|
10.1
x
|
-63.3
x
|
23.6
x
|
16.7
x
|
14.5
x
|
13.7
x
|
Yield
|
2.14%
|
2.23%
|
2.08%
|
3.07%
|
1.94%
|
2.54%
|
2.64%
|
2.92%
|
Capitalization / Revenue
|
1.22
x
|
1.64
x
|
2.99
x
|
1.86
x
|
2.93
x
|
2.26
x
|
2.06
x
|
2.01
x
|
EV / Revenue
|
1.55
x
|
1.7
x
|
2.9
x
|
1.74
x
|
2.72
x
|
1.96
x
|
1.71
x
|
1.58
x
|
EV / EBITDA
|
16.7
x
|
11.2
x
|
7.32
x
|
50.8
x
|
14.2
x
|
8.45
x
|
7.31
x
|
6.93
x
|
EV / FCF
|
-
|
16.6
x
|
-
|
-
|
-
|
14.8
x
|
16.7
x
|
14.2
x
|
FCF Yield
|
-
|
6.01%
|
-
|
-
|
-
|
6.74%
|
5.99%
|
7.05%
|
Price to Book
|
2.1
x
|
1.87
x
|
1.83
x
|
1.3
x
|
2.06
x
|
1.55
x
|
1.44
x
|
1.35
x
|
Nbr of stocks (in thousands)
|
1,507,920
|
1,507,920
|
1,500,163
|
1,485,873
|
1,493,950
|
1,493,950
|
-
|
-
|
Reference price
2 |
15.42
|
14.79
|
15.85
|
10.76
|
17.02
|
13.71
|
13.71
|
13.71
|
Announcement Date
|
4/25/20
|
4/23/21
|
3/30/22
|
3/27/23
|
4/15/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
18,998
|
13,576
|
7,952
|
8,593
|
8,674
|
9,076
|
9,943
|
10,174
|
EBITDA
1 |
1,762
|
2,062
|
3,153
|
294.6
|
1,663
|
2,103
|
2,320
|
2,316
|
EBIT
1 |
1,338
|
1,472
|
2,733
|
-153
|
1,228
|
1,412
|
1,603
|
1,674
|
Operating Margin
|
7.04%
|
10.85%
|
34.37%
|
-1.78%
|
14.16%
|
15.56%
|
16.12%
|
16.45%
|
Earnings before Tax (EBT)
1 |
1,331
|
1,457
|
2,724
|
-160.5
|
1,221
|
1,490
|
1,690
|
1,789
|
Net income
1 |
1,001
|
1,126
|
2,359
|
-256.5
|
1,071
|
1,247
|
1,430
|
1,494
|
Net margin
|
5.27%
|
8.29%
|
29.66%
|
-2.99%
|
12.35%
|
13.74%
|
14.39%
|
14.68%
|
EPS
2 |
0.6600
|
0.7500
|
1.570
|
-0.1700
|
0.7200
|
0.8204
|
0.9474
|
0.9981
|
Free Cash Flow
1 |
-
|
1,389
|
-
|
-
|
-
|
1,199
|
1,016
|
1,132
|
FCF margin
|
-
|
10.23%
|
-
|
-
|
-
|
13.21%
|
10.22%
|
11.13%
|
FCF Conversion (EBITDA)
|
-
|
67.33%
|
-
|
-
|
-
|
57%
|
43.8%
|
48.87%
|
FCF Conversion (Net income)
|
-
|
123.34%
|
-
|
-
|
-
|
96.15%
|
71.05%
|
75.78%
|
Dividend per Share
2 |
0.3300
|
0.3300
|
0.3300
|
0.3300
|
0.3300
|
0.3486
|
0.3614
|
0.3997
|
Announcement Date
|
4/25/20
|
4/23/21
|
3/30/22
|
3/27/23
|
4/15/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
2,103
|
2,049
|
2,541
|
2,471
|
2,896
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
0.5800
|
-0.3719
|
0.1000
|
0.0500
|
0.0500
|
0.1774
|
0.2900
|
0.2200
|
0.0300
|
0.1976
|
0.2200
|
0.2300
|
0.3300
|
0.3000
|
0.2800
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/30/22
|
4/25/22
|
8/19/22
|
10/25/22
|
3/27/23
|
4/24/23
|
8/25/23
|
10/27/23
|
4/15/24
|
4/25/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
6,199
|
818
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
692
|
1,020
|
1,792
|
2,706
|
3,521
|
4,429
|
Leverage (Debt/EBITDA)
|
3.518
x
|
0.3968
x
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
1,389
|
-
|
-
|
-
|
1,199
|
1,016
|
1,132
|
ROE (net income / shareholders' equity)
|
9.28%
|
9.76%
|
18.4%
|
-2.04%
|
8.75%
|
9.63%
|
10.2%
|
10%
|
ROA (Net income/ Total Assets)
|
4.07%
|
5.56%
|
14.3%
|
-
|
-
|
6.65%
|
7.39%
|
7.47%
|
Assets
1 |
24,593
|
20,253
|
16,518
|
-
|
-
|
18,747
|
19,365
|
20,008
|
Book Value Per Share
2 |
7.360
|
7.910
|
8.660
|
8.270
|
8.250
|
8.840
|
9.520
|
10.20
|
Cash Flow per Share
2 |
1.110
|
1.180
|
1.870
|
1.520
|
1.720
|
1.100
|
1.090
|
1.440
|
Capex
1 |
729
|
403
|
503
|
402
|
668
|
506
|
416
|
413
|
Capex / Sales
|
3.84%
|
2.96%
|
6.32%
|
4.68%
|
7.7%
|
5.57%
|
4.19%
|
4.06%
|
Announcement Date
|
4/25/20
|
4/23/21
|
3/30/22
|
3/27/23
|
4/15/24
|
-
|
-
|
-
|
Last Close Price
13.71
CNY Average target price
14.87
CNY Spread / Average Target +8.48% Consensus |
1st Jan change
|
Capi.
|
---|
| -19.45% | 2.87B | | +37.12% | 6.02B | | -22.80% | 4.19B | | +5.44% | 3.25B | | -10.35% | 2.37B | | +42.72% | 1.89B | | -5.87% | 1.58B | | -18.53% | 1.54B | | -15.33% | 1.5B | | +45.78% | 1.45B |
Alternative Medicine
|